Waystar Corp (WAY) - Forward P/S Multiple

Brandmark of waystar.com (WAY)

Waystar Holding Corp. generates stable revenue based on cloud billing, which is mission-critical for clinics. This forward P/S chart illustrates market expectations, where the 1.60 level represents the current value. Waystar Holding Corp. profits from B2B contracts with major US medical centers by automating settlements. High software integration into client processes allows the brand to maintain its leadership and preserve high margins.

WAY Waystar: Market Cap to Future Revenue Ratio in the range 06/08/2024 - 11/14/2026

Waystar Corp - analytical breakdowns and key metrics (WAY)

- stock price and consensus target price:
Comprehensive company analysis:WAY (Waystar)
Product sample of Waystar Corp

The forward P/S is calculated as the ratio of the current market value of Waystar Holding Corp. (WAY) to expected annual sales, reflecting the dynamics of business revaluation by investors between reporting periods. For this cloud-based digital payment logistics platform for healthcare, the forward revenue multiple demonstrates the extent to which the market is willing to award a premium for billing automation efficiency and the reduction of administrative costs within the healthcare sector.

Competitor analysis for Waystar Holding Corp.

Veeva - Forward Price-to-Revenue Multiple|Forward Price to Sales DOCS|HealthEquity Corp - Forward P/S Multiple|Forward Price to Sales CRVL (CorVel Corp.)|Privia Health Group (PRVA) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio huronconsultinggroup.com (HURN)|Price-to-Projected Revenue Ratio Certara|Price-to-Projected Revenue Ratio OMCL|Forward P/S Multiple GDRX|Schrodinger Corp - Market Cap to Projected Revenue|Forward P/S Multiple PHR (Phreesia, Inc.)|Market Cap to Expected Sales Ratio omadahealth.com (OMDA)|EVH - Price-to-Projected Revenue Ratio|HSTM (HealthStream Inc) - Market Cap to Projected Revenue|DH: Forward P/S Multiple|Projected Price to Revenue Consensus Corp CCSI|Forward Price-to-Revenue Multiple AGL|ABSI: Forward Price to Sales|Forward P/S Multiple SY|Forward Price-to-Revenue Multiple NRC Health NRC|Price-to-Projected Revenue Ratio Spok Corp SPOK|OptimizeRx Inc. (OPRX) - Market Cap to Future Revenue Ratio|TBRG - Price-to-Projected Revenue Ratio|Forward Price to Sales SLP (simulations-plus.com)|sophiagenetics.com (SOPH) - Price-to-Projected Revenue Ratio|Future Price to Revenue HCAT (Health Catalyst Inc.)|Forward Price-to-Revenue Multiple CCLD|Research Solutions Inc. (RSSS) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple DLHC (DLH Holdings Corp.)|Forward Price-to-Revenue Multiple onemednet.com ONMD|Forward P/S Multiple SCNX (Scienture)|Forward P/S Multiple Healthcare Triangle Inc HCTI|ISPC: Forward Price-to-Revenue Multiple|Market Cap to Future Revenue Ratio Bullfrog AI Holdings|WORX: Forward P/S Multiple|MSPR - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple ICCT|MEDS (TRxADE HEALTH Inc) - Price to Expected Revenue Ratio|Forward Price-to-Revenue Multiple ORGS (Orgenesis Corp)|RCM (r1rcm.com) - Forward Price to Sales|Price-to-Projected Revenue Ratio Sharecare, Inc. SHCR|STRM - Forward Price-to-Revenue Multiple|Syra Health - Forward P/S Multiple|Market Cap to Future Revenue Ratio Apollo Medical Holdings|MODN: Forward P/S Multiple|Market Cap to Projected Revenue NXGN